Alexion, part of AstraZeneca (AZN), said that the FDA has approved Koselugo for the treatment of adults with neurofibromatosis.
https://seekingalpha.com/news/4524489-astrazenecas-alexion-gets-fda-approval-for-koselugo
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.